NCT00738400 - Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Erectile DysfunctionMetabolic Syndrome

Interventions

DRUG

Vardenafil (Levitra, BAY38-9456)

Vardenafil 10 mg tablets daily for 4 weeks, vardenafil 5 mg / 10 mg / 20 mg tablets for consecutive 4 weeks

DRUG

Placebo

Matching placebo tablets daily for 4 weeks, placebo tablets daily for consecutive 4 weeks

Trial Locations (19)

12107

Berlin

14197

Berlin

20354

Hamburg

28816

Stuhr

35039

Marburg

41515

Grevenbroich

42103

Wuppertal

45468

Mülheim

51373

Leverkusen

53119

Bonn

54290

Trier

56068

Koblenz

56269

Dierdorf

60385

Frankfurt am Main

66424

Homburg

93055

Regensburg

93413

Cham

01307

Dresden

04109

Leipzig